Last checked at 15 Jan 2020 10:32
15 January 2020
IXICO plc
("IXICO" or the "Company")
Exercise of Options and PDMR Dealings
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 10 January 2020 that John Hall, SVP Corporate Development and PDMR, exercised 75,000 options with an exercise price of 34p.
The Company has also received notification on 10 January 2020 that Robin Wolz, SVP Research & Development and PDMR, exercised 83,882 options of which 45,176 were exercisable at 30.5p and 38,706 were exercisable at 34p. The 83,882 shares were sold to a third party at an average price of 87.6p.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| John James Hall
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| PDMR (SVP Corporate Development) | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| IXICO plc | |||
b)
| LEI
| 2138005M1F59O6HWSA97 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares in IXICO plc | |||
Identification code | GB00BCLY7L40 | ||||
| |||||
b)
| Nature of the transaction
| Exercise of options | |||
c)
| Price(s) and volume(s) |
|
|
|
|
| Exercise Price(s) | Volume(s) |
| ||
| 34p | 75,000 |
| ||
|
|
|
| ||
d)
| Aggregated information | ||||
- Aggregated volume | 75,000 shares | ||||
- Price | 34p | ||||
e)
| Date of the transaction
| 10/1/20 | |||
f)
| Place of the transaction
| N/A | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Robin Wolz
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| PDMR (SVP Research & Development) | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| IXICO plc | |||
b)
| LEI
| 2138005M1F59O6HWSA97 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares in IXICO plc | |||
Identification code | GB00BCLY7L40 | ||||
| |||||
b)
| Nature of the transaction
| Exercise of options | |||
c)
| Price(s) and volume(s) |
|
|
|
|
| Exercise Price(s) | Volume(s) |
| ||
| 30.5p | 45,176 |
| ||
| 34p | 38,706 |
| ||
|
|
|
| ||
d)
| Aggregated information | ||||
- Aggregated volume | 83,882 shares | ||||
- Price | 32.1p | ||||
e)
| Date of the transaction
| 10/1/20 | |||
f)
| Place of the transaction
| N/A | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
|
| ||||
a)
| Name
| Robin Wolz
|
| |||
2
| Reason for the notification
|
| ||||
a)
| Position/status
| PDMR (SVP Research & Development) |
| |||
b)
| Initial notification /Amendment
| Initial notification |
| |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
| ||||
a)
| Name
| IXICO plc |
| |||
b)
| LEI
| 2138005M1F59O6HWSA97 |
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares in IXICO plc |
| |||
| ||||||
Identification code | GB00BCLY7L40 |
| ||||
|
| |||||
b)
| Nature of the transaction
| Sale |
| |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) Date | Volume(s) |
|
| ||
| 92p 10/1/20 | 18,395 |
|
| ||
| 90p 13/1/20 | 18,395 |
|
| ||
| 85p 13/1/20 | 47,092 |
|
| ||
|
|
|
|
| ||
d)
| Aggregated information |
| ||||
| ||||||
- Aggregated volume | 83,882 shares |
| ||||
| ||||||
- Price | 87.6p |
| ||||
| ||||||
e)
| Date of the transaction
| 10/1/20 and 13/1/20 |
| |||
f)
| Place of the transaction
| London Stock Exchange |
| |||
IXICO plc | +44 (0) 20 3763 7498 | |||||
Giulio Cerroni, Chief Executive Officer | ||||||
Grant Nash, Chief Financial Officer
| ||||||
Cenkos Securities PLC (Nominated adviser and sole broker) | +44 (0) 20 7397 8900 | |||||
Giles Balleny / Max Gould (Corporate Finance) | ||||||
Michael F Johnson / Russell Kerr (Sales) | ||||||
Optimum Strategic Communications | +44 (0) 203 950 9144 | |||||
Mary Clark / Supriya Mathur/Manel Mateus | ||||||
ixico@optimumcomms.com | ||||||